Amundi Prime Europe UCITS ETF DR (C)
Solactive GBS Developed Markets Europe Large & Mid Cap
- ISIN
- LU2089238039
- Issuer
- Amundi ETF
- TER
- 0.05%
- Latest closing price
- N/A
- Fund Size
- €298 m As of: Sep 30, 2026
- Domicile
- Luxembourg
- Distribution Policy
- Accumulating
- Replication Method
- Physical
- Base Currency
- EUR
- WKN / Ticker
- A2PWMH / PRAE
Data availability
Data is available for 2 of 5 areas for this fund.
- Master data (TER, index, size): As of: Sep 30, 2026
- Closing price: not available
- Price history (at least 20 prices): not available
- Holdings: As of: Jul 24, 2026
- Risk figures: not available
Missing information is marked as “not available” and is not estimated. The issuer’s documents are authoritative.
At a glance
Amundi Prime Europe UCITS ETF DR (C) (ISIN LU2089238039) is a fund from Amundi ETF (fund type: ETF). Benchmark index: Solactive GBS Developed Markets Europe Large & Mid Cap. Its ongoing charges (TER) are 0.05% per year. The fund size is €298 m. Distribution policy: Accumulating. Replication: Physical. Fund domicile: Luxembourg.
- Launch date 15.01.2020 (6 years)
- Number of Holdings 399
- Strategy Passive (index tracking)
- Base Currency EUR
- Currency hedging No
- Distribution Policy Accumulating
- Replication Method Physical
- Securities lending Yes
- Domicile LU
- UCITS Compliant Yes
Price development
Pure price change based on stored closing prices; distributions, purchase costs and taxes are not included. Different currencies and index types (price or total return index) can distort the comparison line. Past performance is not a reliable indicator of future results.
Risk figures (12 months)
No calculated risk figures are available for this fund yet.
The official summary risk indicator (SRI, scale 1–7) is in the issuer’s key information document (KID). The figures here are historical values and do not replace it.
Documents
We have no documents stored for this fund. The key information document (KID), factsheet and prospectus are provided by the issuer.
Search documents at Amundi ETFTracking difference and tracking error
We have no comparison series stored for this fund’s index, so a tracking analysis is not possible.
What does the fund invest in?
As of 09.09.2026 · Source: justETF / etfdbSector Breakdown
-
Financials 26.6%
-
Industrials 18.1%
-
Health care 12.6%
-
Technology 9.2%
-
Consumer staples 8.2%
-
Consumer discretionary 6.0%
-
Energy 5.6%
-
Basic materials 5.5%
-
Utilities 4.5%
-
Other 3.7%
Country Breakdown
-
United Kingdom 22.8%
-
France 13.7%
-
Germany 13.5%
-
Switzerland 13.2%
-
Netherlands 8.7%
-
Sweden 6.1%
-
Spain 6.0%
-
Italy 5.3%
-
Denmark 2.6%
-
Finland 1.9%
-
All others 6.1%
Holdings
Showing 10 holdings that together make up 21.9 % of fund assets. (out of 399 holdings in total).
| # | Name | ISIN | Sector | Country | Weight |
|---|---|---|---|---|---|
| 1 | ASML Holding NV | NL0010273215 | – | – | 4.97 % |
| 2 | HSBC Holdings Plc | GB0005405286 | – | – | 2.61 % |
| 3 | Roche Holding AG | CH1499059983 | – | – | 2.24 % |
| 4 | Novartis AG | CH0012005267 | – | – | 2.07 % |
| 5 | Nestlé SA | CH0038863350 | – | – | 1.87 % |
| 6 | AstraZeneca PLC | GB0009895292 | – | – | 1.86 % |
| 7 | Shell Plc | GB00BP6MXD84 | – | – | 1.82 % |
| 8 | Siemens AG | DE0007236101 | – | – | 1.63 % |
| 9 | Banco Santander SA | ES0113900J37 | – | – | 1.45 % |
| 10 | Allianz SE | DE0008404005 | – | – | 1.36 % |
Cost calculator
What does this ETF cost you per year – and over your whole investment horizon?Simplified model based on the TER, excluding order fees, spreads, taxes and tracking difference. Not investment advice.
Alternatives on the same index
Other ETFs tracking the Solactive GBS Developed Markets Europe Large & Mid Cap – cheapest first.| Name | TER | Fund Volume | Distribution |
|---|---|---|---|
| Amundi Prime Europe UCITS ETF DR (C) This fund | 0.05% | €298 m | Accumulating |
| Amundi Prime Europe UCITS ETF DR (D) | 0.05% | €263 m | Distributing |
Frequently asked questions about the Amundi Prime Europe UCITS ETF DR (C)
All information without guarantee. It is provided for information purposes only and does not constitute investment advice.